Mengxue Gao
State Key Laboratory Of Synthetic Biology, Tianjin Key Laboratory Of Biological And Pharmaceutical Engineering
Tianjin, 300350, China
Tianjin, 300350, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Propionate-engineered probiotics reduce radiation-induced intestinal damage.
Journal: Bioresources and bioprocessing
Published: November 10, 2025
Synthetic microbial consortia based on quorum-sensing for disease therapy.
Journal: Bioresources and bioprocessing
Published: July 19, 2025
An Engineered Probiotic Consortium Based on Quorum-Sensing for Colorectal Cancer Immunotherapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 08, 2025
A dual-functional fluorescent probe for biosystem imaging and food safety monitoring of HSO3- with high selectivity and sensitivity.
Journal: Analytical and bioanalytical chemistry
Published: January 03, 2025
Butyrate-engineered yeast activates Nppa and Sgcg genes and reduces radiation-induced heart damage via the gut-heart axis.
Journal: Pharmacological research
Published: December 23, 2024
Noncanonical amino acid-aided synthesis of anti-PD-L1 bispecific nanobody for colon cancer immunotherapy.
Journal: Communications biology
Published: December 12, 2024
Streptococcus anginosus promotes gastric inflammation, atrophy, and tumorigenesis in mice.
Journal: Cell
Published: October 26, 2024
A tailored series of engineered yeasts for the cell-dependent treatment of inflammatory bowel disease by rational butyrate supplementation.
Journal: Gut microbes
Published: February 21, 2024
A synthetic microbial consortium protects against obesity by regulating vitamin B6 metabolism.
Journal: Gut microbes
Published: January 25, 2024
Novel bispecific nanobody mitigates experimental intestinal inflammation in mice by targeting TNF-α and IL-23p19 bioactivities.
Journal: Clinical and translational medicine
Published: October 30, 2023
Propionate-producing engineered probiotics ameliorated murine ulcerative colitis by restoring anti-inflammatory macrophage via the GPR43/HDAC1/IL-10 axis.
Journal: Bioengineering & translational medicine
Published: August 29, 2023
Peptostreptococcus anaerobius mediates anti-PD1 therapy resistance and exacerbates colorectal cancer via myeloid-derived suppressor cells in mice.
Journal: Nature microbiology
Published: January 12, 2023
Last Updated: 09/26/2026